ClinicalTrials.Veeva

Menu

The Influence of Oxytocin on Pair-bonding and Emotion Regulation

U

University Hospital Bonn (UKB)

Status and phase

Completed
Early Phase 1

Conditions

Healthy

Treatments

Drug: Syntocinon-Spray

Study type

Interventional

Funder types

Other

Identifiers

NCT02501837
OXT_BOND

Details and patient eligibility

About

The neuropeptide oxytocin (OXT) has been identified as a key modulator of human social behavior and it has been recently shown that OXT also contributes to pair-bonding in men. However, it is still elusive whether OXT has similar effects in women. In the present study, the investigators examine the effect of intranasal OXT on behavioral ratings of and neural responses to the male partner in female participants. In a second experiment, the modulatory effect of OXT on emotion regulation is investigated.

Enrollment

40 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy female volunteers
  • In a heterosexual relationship

Exclusion criteria

  • Current or past psychiatric disease
  • Current or past physical illness
  • Psychoactive medication
  • Pregnant or lactating

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

40 participants in 2 patient groups, including a placebo group

Oxytocin
Experimental group
Description:
24 IU Oxytocin (Syntocinon spray), intranasal application 30 min prior to the experiment
Treatment:
Drug: Syntocinon-Spray
Placebo
Placebo Comparator group
Description:
Intranasal application, containing all ingredients except for the peptide, 3 puffs per nostril
Treatment:
Drug: Syntocinon-Spray

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems